LIVE

€100.00 ▲+29.35%

/Plasma Freeze/Reshiram

Variants

STANDARD · Conviction 5/10

Reshiram

Plasma Freeze · #17 · Rare Holo

Reference NM

€4.77

External reference · raw NM

PSA 9

€43.73

USD source

PSA 10

€481.16

USD source

Composite

4.7

Live raw NM price unavailable from primary source — showing external reference.

Cardmarket (EUR) →eBay (US) →

Buy range€2.76 – €3.60Above market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

4.7

SCORE / 10

Liquidity

9.9

Scarcity

10.0

Era potential

3.3

Friction

4.5

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 9.60%Total population

PSA 10

PSA 9

PSA 8

Total graded

250

Gem rate 9.60%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

The Plasma Freeze Reshiram (#17) currently trades at €4.77 in the raw market. By market value it ranks #47 of 122 in Plasma Freeze — the 60th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated high. Market data is informational only and does not constitute investment advice.